AbCellera Biologics (ABCL) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
ABCL is expected to report earnings to rise 31.10% to -13 cents per share on February 25
Q4'24
Est.
$-0.13
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.01
Q1'24
Missed
by $0.02
Q4'23
Missed
by $0.05
The last earnings report on November 04 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 3.14M shares outstanding, the current market capitalization sits at 824.07M.